Rare Genetic Condition: Amanda Abbington’s Daughters’ Diagnosis Revealed
- The entertainment industry, often focused on premieres and box office numbers, is occasionally touched by stories that resonate far beyond the screen.
- KAND, as described by Burritt, is a rare and severe neurodegenerative disease caused by mutations in the KIF1A gene.
- The impact of a KAND diagnosis is profound, as Burritt described to Inside Edition Digital.
The entertainment industry, often focused on premieres and box office numbers, is occasionally touched by stories that resonate far beyond the screen. Amanda Burritt, a mother whose daughter Emma lives with KIF1A Associated Neurological Disorder (KAND), is one such example. Her advocacy for finding a cure for this incredibly rare disease has garnered attention, highlighted recently by an feature in multiple outlets.
KAND, as described by Burritt, is a rare and severe neurodegenerative disease caused by mutations in the KIF1A gene. It’s a condition affecting approximately 550 known families worldwide. The diagnosis came for Emma Burritt after months of testing, finally confirmed on , when she was still a young child. Prior to the diagnosis, Emma had begun to fall behind developmental milestones around six months old, exhibiting low muscle tone and difficulties with sitting and crawling. Doctors also noted optic nerve atrophy and possible cortical visual impairment, but the underlying cause remained elusive for a significant period.
The impact of a KAND diagnosis is profound, as Burritt described to Inside Edition Digital. The realization that Emma’s condition was progressive and degenerative was “devastating,” prompting her and her family to immediately shift into “fight or flight mode” and dedicate themselves to finding the best possible care and support for their daughter. This led to a significant life change, with the family relocating to find resources offering the best therapy, schools, and overall support for Emma.
Burritt’s story isn’t isolated. While KAND itself affects a small number of families, the broader landscape of rare diseases presents similar challenges. Another mother, Amanda Thomas, is navigating the complexities of an even rarer condition, as reported in a BBC News article. Her son, Jack, is one of only 16 children globally known to have a mutation of the PPFIBP1 gene. This condition is so rare it doesn’t even have a formal name yet. Jack’s condition results in blindness, frequent seizures, and a limited prognosis, with doctors indicating a life expectancy limited to childhood.
Thomas, like Burritt, has sought connection with other families facing similar circumstances. She has connected with one other parent whose daughter with the PPFIBP1 mutation passed away at the age of two. The experience of sharing experiences and offering mutual support proved invaluable, highlighting the importance of community in navigating these incredibly difficult journeys. “She felt so blessed to have her little girl in her life, even for a short time and you could just see how much love was there,” Thomas shared, emphasizing the emotional weight of these rare diagnoses.
The search for answers and potential treatments for these rare conditions is often hampered by the limited number of cases. The small patient population makes it difficult to conduct large-scale clinical trials and attract significant research funding. However, the dedication of parents like Burritt and Thomas is driving awareness and fostering collaboration within the medical community. Burritt’s advocacy, for example, has been featured in an Inside Edition segment and a blog post on KIF1A.org, amplifying the need for research into KAND.
While the stories of Emma Burritt and Jack Thomas are deeply personal, they reflect a larger trend within the rare disease community. The challenges faced by these families – from obtaining accurate diagnoses to accessing specialized care – underscore the need for increased awareness, research funding, and support networks. Amanda Woodley’s story, highlighted on Rare Disease Day 2026, further illustrates the long-term impact of rare conditions, as she lives with severe intellectual and physical disabilities resulting from an adverse reaction to the MMR inoculation and a subsequent diagnosis of Rett Syndrome in .
These narratives serve as a powerful reminder that the entertainment industry’s reach extends beyond escapism and commercial success. By amplifying stories like these, platforms can contribute to a greater understanding of the challenges faced by individuals and families affected by rare diseases, and potentially inspire action towards finding cures and improving quality of life. The dedication of these mothers, fighting for their children and connecting with others in similar situations, is a testament to the enduring power of parental love and the importance of community in the face of adversity.